Skip Navigation


European Heart Journal Advance Access originally published online on October 19, 2007
European Heart Journal 2007 28(22):2819-2820; doi:10.1093/eurheartj/ehm457
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/22/2819    most recent
ehm457v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bonny, A.
Right arrow Articles by Frank, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonny, A.
Right arrow Articles by Frank, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome

Aimé Bonny

Hôpital Pitié Salpêtrière
Institut de Cardiologie
Unité de Rythmologie
47-85 Boulevard de l'Hôpital
Paris
France
Hôpital Saint Camille
Service de Cardiologie
Bry sur marne
France

Joelci Tonet

Hôpital Pitié Salpêtrière
Institut de Cardiologie
Unité de Rythmologie
47-85 Boulevard de l'Hôpital
Paris
France

Guy Fontaine

Hôpital Pitié Salpêtrière
Institut de Cardiologie
Unité de Rythmologie
47-85 Boulevard de l'Hôpital
Paris
France

Robert Frank

Hôpital Pitié Salpêtrière
Institut de Cardiologie
Unité de Rythmologie 47-85 Boulevard de l'Hôpital
Paris
France

Tel: +33 628464884 Fax: +33 49831009 E-mail address: aimebonny{at}yahoo.fr

In reference to the original and interesting study by Sarkozy et al.,1 we would like to point out the following comments regarding their inclusion criteria in this original study.

The study found the difference in appearance of coved-type ECG during follow-up of patients with baseline type II, type III, and normal ECG, respectively (56, 17, and 0%). Although type II and III are not diagnostic, these findings indicate that they do not have the same significance. Moreover, normal resting ECG in the so-called high-risk patients seems not to have dynamic changes, leading to diagnostic coved type. Thus, it is not clearly mentioned whether each patient with baseline normal resting ECG (nine patients) has the following risk factors: positive family history of sudden death (55% of all 47 studied), syncope prior to ICD (55%), both (30%), or inducible EP study (83%); considering that spontaneous coved type had not been seen during the follow-up period. Did they find SCN5A mutation or other mutation in these nine patients with normal resting ECG? What is the age distribution in the follow-up period? Knowing that if they were too young, BS phenotype might not have enough time to appear. None of them had appropriate shock. ICD implantation in patients with non-spontaneous coved-type pattern in conjunction with family history of sudden death and positive EP study is considered as class IIb.2 The consensus did not mention specifically the place of normal spontaneous ECG in the assessment of subjects with other high-risk factors of sudden death in Brugada syndrome. However, the authors' findings concerning baseline normal resting ECG seem to be confident with the highest negative predictive value as marker of sudden death. The authors' conclusion did not notice this fact, which is relevant from our point of view.

References

  1. Sarkozy A, Boussy T, Kourgiannides G, Chierchia G-B, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg MD, Brugada P. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J (2007) 28:334–344.[Abstract/Free Full Text]
  2. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the Second Consensus Conference. Circulation (2005) 111:659–670.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/22/2819    most recent
ehm457v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bonny, A.
Right arrow Articles by Frank, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonny, A.
Right arrow Articles by Frank, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?